Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis
Naser L. Rezk(University of North Carolina at Chapel Hill), Byung Hwa Jung(Korea-China Science & Technology Cooperation Center), Myron S. Cohen(University of North Carolina at Chapel Hill), Paul W. Stewart(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Amanda Corbett(University of North Carolina at Chapel Hill), Arlene S. Bridges(University of North Carolina at Chapel Hill), Julie B. Dumond(University of North Carolina at Chapel Hill), Kristine B. Patterson(University of North Carolina at Chapel Hill), Rosa F. Yeh(Seattle Cancer Care Alliance)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557